Search results
Showing 2386 to 2400 of 8974 results
We are listening to your views on this Interventional procedures guidance. Comments close 10 April 2026.
Awaiting development Reference number: GID-TA11811 Expected publication date: TBC
AK-OTOF for treating hearing loss caused by otoferlin gene variants [ID6735]
Awaiting development Reference number: GID-TA11962 Expected publication date: TBC
We are listening to your views on this Technology appraisal guidance. Comments close 28 April 2026.
Awaiting development Reference number: GID-TA11971 Expected publication date: TBC
Awaiting development Reference number: GID-TA11976 Expected publication date: TBC
Awaiting development Reference number: GID-TA11945 Expected publication date: TBC
Sevabertinib for untreated HER2-positive advanced non-small-cell lung cancer [ID6616]
Awaiting development Reference number: GID-TA11814 Expected publication date: TBC
Awaiting development Reference number: GID-TA11820 Expected publication date: TBC
Avexitide for treating hypoglycaemia after bariatric surgery [ID6725]
Awaiting development Reference number: GID-TA11824 Expected publication date: TBC
Awaiting development Reference number: GID-TA11921 Expected publication date: TBC
Nipocalimab for treating warm autoimmune haemolytic anaemia [ID6642]
Awaiting development Reference number: GID-TA11855 Expected publication date: TBC
Awaiting development Reference number: GID-TA11838 Expected publication date: TBC
Awaiting development Reference number: GID-TA11936 Expected publication date: TBC
Awaiting development Reference number: GID-TA11229 Expected publication date: TBC